Cytokinetics (CYTK) Convertible Debt (2019 - 2026)
Cytokinetics (CYTK) reported Convertible Debt of $732.77 million for Q3 2026, down 17.6% from $889.52 million a year earlier and down 15.9% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Convertible Debt (2019 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics posted Convertible Debt of $869.6 million, up 57.4% from FY2024.
- Convertible Debt has increased for six consecutive years, with a five-year compound annual growth rate of 57.6% (FY2020 to FY2025).
- By year, Convertible Debt came in at $552.37 million in FY2024 (+0.6%), $548.99 million in FY2023 (+0.6%), $545.81 million in FY2022 (+471.7%) and $95.47 million in FY2021 (+6.7%).
- The Q3 2026 figure ranks as the lowest quarterly Convertible Debt since Q2 2025.
- Year over year, Convertible Debt gained in seven of the last eight quarters, with growth averaging 27.2%.
- The high point for year-over-year Convertible Debt in five years was Q3 2022 (growth of 480.5%); the low point was Q3 2026 (a decline of 17.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $871.53 million (Q2 2026), $870.51 million (Q1 2026) and $869.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 732.77 Mn |
| Jun 30, 2026 | 871.53 Mn |
| Mar 31, 2026 | 870.51 Mn |
| Dec 31, 2025 | 869.60 Mn |
| Sep 30, 2025 | 889.52 Mn |
| Jun 30, 2025 | 553.99 Mn |
| Mar 31, 2025 | 553.14 Mn |
| Dec 31, 2024 | 552.37 Mn |
| Sep 30, 2024 | 551.48 Mn |
| Jun 30, 2024 | 550.60 Mn |
| Mar 31, 2024 | 549.79 Mn |
| Dec 31, 2023 | 548.99 Mn |
| Sep 30, 2023 | 548.13 Mn |
| Jun 30, 2023 | 547.29 Mn |
| Mar 31, 2023 | 546.51 Mn |
| Dec 31, 2022 | 545.81 Mn |
| Sep 30, 2022 | 544.99 Mn |
| Jun 30, 2022 | 134.67 Mn |
| Mar 31, 2022 | 134.51 Mn |
| Dec 31, 2021 | 95.47 Mn |
API Access
Cytokinetics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();